FDA Approves Eisai's Halaven As Treatment For Liposarcoma

Halaven has received the FDA's approval as a chemotherapy option. It adds to the list of treatments that could be prescribed to patients with liposarcoma, a soft tissue sarcoma that forms in fat cells.